Update in lung cancer 2005

被引：6
作者：
Jett, JR
Miller, YE
机构：
[1] Denver Vet Affairs Med Ctr, Pulm & Crit Care Med Sect, Denver, CO 80220 USA
[2] Mayo Coll Med, Rochester, MN USA
[3] Univ Colorado, Denver, CO 80202 USA
[4] Hlth Sci Ctr, Denver, CO USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2006年 / 173卷 / 07期
关键词：
D O I：
10.1164/rccm.2601008
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：695 / 697
页数：3
相关论文
共 35 条
  • [1] The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial
    Anthonisen, NR
    Skeans, MA
    Wise, RA
    Manfreda, J
    Kanner, RE
    Connett, JE
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) : 233 - 239
  • [2] Measurement of hypoxia-related parameters in bronchial mucosa by use of optical spectroscopy
    Bard, MPL
    Amelink, A
    Hegt, VN
    Graveland, WJ
    Sterenborg, HJCM
    Hoogsteden, HC
    Aerts, JGJV
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (10) : 1178 - 1184
  • [3] Early lung cancer detection using spiral computed tomography and positron emission tomography
    Bastarrika, G
    García-Velloso, MJ
    Lozano, MD
    Montes, U
    Torre, W
    Spiteri, N
    Campo, A
    Seijo, L
    Alcaide, AB
    Pueyo, J
    Cano, D
    Vivas, I
    Cosín, O
    Domínguez, P
    Serra, P
    Richter, JA
    Montuenga, L
    Zulueta, JJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (12) : 1378 - 1383
  • [4] Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials
    Bell, DW
    Lynch, TJ
    Haserlat, SM
    Harris, PL
    Okimoto, RA
    Brannigan, BW
    Sgroi, DC
    Muir, B
    Riemenschneider, MJ
    Iacona, RB
    Krebs, AD
    Johnson, DH
    Giaccone, G
    Herbst, RS
    Manegold, C
    Fukuoka, M
    Kris, MG
    Baselga, J
    Ochs, JS
    Haber, DA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8081 - 8092
  • [5] Lung adenocarcinoma global profiling identifies type II transforming growth factor-β receptor as a repressor of invasiveness
    Borczuk, AC
    Kim, HK
    Yegen, HA
    Friedman, RA
    Powell, CA
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (06) : 729 - 737
  • [6] CAPPUZZO F, 2005, JNCI-J NATL CANCER I, V97, P1
  • [7] 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer
    Carpagnano, GE
    Foschino-Barbaro, MP
    Mulé, G
    Resta, O
    Tommasi, S
    Mangia, A
    Carpagnano, F
    Stea, G
    Susca, A
    Di Gioia, G
    De Lena, M
    Paradiso, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (06) : 738 - 744
  • [8] CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion
    Chen, YQ
    Shi, HZ
    Qin, XJ
    Mo, WN
    Liang, XD
    Huang, ZX
    Yang, HB
    Wu, C
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (11) : 1434 - 1439
  • [9] Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer
    Coté, ML
    Kardia, SLR
    Wenzlaff, AS
    Ruckdeschel, JC
    Schwartz, AG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (24): : 3036 - 3042
  • [10] Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
    Eberhard, DA
    Johnson, BE
    Amler, LC
    Goddard, AD
    Heldens, SL
    Herbst, RS
    Ince, WL
    Jänne, PA
    Januario, T
    Johnson, DH
    Klein, P
    Miller, VA
    Ostland, MA
    Ramies, DA
    Sebisanovic, D
    Stinson, JA
    Zhang, YR
    Seshagiri, S
    Hillan, KJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5900 - 5909
1234